Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Change in Cash (2016 - 2026)

Biomerica's Change in Cash history spans 17 years, with the latest figure at -$1.2 million for Q1 2026.

  • Quarterly results put Change in Cash at -$1.2 million for Q1 2026, down 275.95% from a year ago — trailing twelve months through Feb 2026 was -$1.7 million (up 23.88% YoY), and the annual figure for FY2025 was -$1.8 million, up 68.1%.
  • Change in Cash for Q1 2026 was -$1.2 million at Biomerica, down from -$510000.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $6.4 million in Q2 2023 to a low of -$4.3 million in Q2 2022.
  • The 5-year median for Change in Cash is -$854000.0 (2023), against an average of -$344756.0.
  • The sharpest move saw Change in Cash soared 823.37% in 2022, then crashed 1195.57% in 2023.
  • Year by year, Change in Cash stood at -$1.0 million in 2022, then increased by 15.28% to -$854000.0 in 2023, then surged by 47.54% to -$448000.0 in 2024, then decreased by 13.84% to -$510000.0 in 2025, then plummeted by 136.67% to -$1.2 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$1.2 million, -$510000.0, and $654000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.